Opportunity Information: Apply for CMS 2W2 27 001
Apply for CMS 2W2 27 001
- The Center for Medicare and Medicaid Services in the health sector is offering a public funding opportunity titled "Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.779.
- This funding opportunity was created on 2026-03-13.
- Applicants must submit their applications by 2026-05-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,300,000.00 in funding.
- The number of recipients for this funding is limited to 15 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Make America Healthy Again - Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE) opportunity is a Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) cooperative agreement that funds a voluntary, three-year service delivery model focused on testing evidence-based "whole-person" functional or lifestyle medicine approaches. The core idea is to move upstream: instead of managing chronic diseases only after they appear and treating each condition in isolation, the model supports prevention and earlier intervention by combining psychological, nutritional, and physical strategies, then tailoring those strategies to the individual. In practical terms, CMS is looking to evaluate whether structured lifestyle-focused interventions can improve health outcomes for Medicare beneficiaries while also lowering overall costs through reduced utilization and better long-term management.
A central feature of this notice is that CMS uses the phrase "whole-person FLM" as a convenient label for a bundle of services often seen in functional or lifestyle medicine that are not currently covered under Medicare. CMS is explicit that this terminology is not meant to set a new industry standard, create new practice guidelines, or establish a new Medicare-covered benefit category. The phrase is purely descriptive for the purposes of this test model, and it should not be interpreted as changing Medicare coverage policy outside the boundaries of this demonstration.
CMS plans to select up to 30 recipients total, with the model running in two cohorts that begin one year apart, in 2026 and 2027. The selection process emphasizes both the clinical logic of the intervention and the operational reality of executing a rigorous evaluation. Applications are judged using five main criteria: (1) the design of the whole-person FLM intervention, including a credible path to cost savings, (2) the plan for beneficiary recruitment and the study design, including how participants will be assigned or randomized, (3) organizational and administrative capacity to run a multi-year service delivery model, (4) data management capabilities to handle extensive reporting and evaluation needs, and (5) the reasonableness and appropriateness of the proposed budget.
Competitive applicants are expected to bring more than a good concept. CMS is signaling that strong proposals will include solid evidence supporting the intervention, along with proof that the applicant has already implemented similar approaches successfully and can show measurable results, including cost savings. Because the model has minimum beneficiary participation targets and substantial data requirements, CMS also cautions that organizations that do not directly provide clinical care will likely need formal partnerships with entities that do (such as practices, clinics, health systems, or other care delivery organizations). The goal is to ensure applicants can actually enroll participants, deliver the intervention as designed, and collect high-quality data suitable for evaluation.
Eligibility is broad and effectively unrestricted at the organizational level, but individuals cannot apply. Examples of eligible applicants include private medical practices, health systems and Accountable Care Organizations (ACOs), academic organizations, functional/lifestyle/preventive/integrative medicine centers, community-based organizations, Federally Qualified Health Centers (FQHCs), Rural Health Clinics (RHCs), Indian Health Service/Tribal/Urban Indian programs (I/T/Us), and local or state governments. Multi-state organizations may apply as well, which supports larger-scale recruitment and implementation strategies.
From the published opportunity details, this is a discretionary funding opportunity (CFDA 93.779) using a cooperative agreement mechanism, which typically means CMS expects substantial involvement in shaping or overseeing how the work is carried out compared with a standard grant. The funding opportunity number is CMS-2W2-27-001, with an application deadline of May 15, 2026. The listed award ceiling is $3,300,000, and the opportunity anticipates 15 awards (while the model description notes up to 30 recipients across two cohorts, implying the total may be split across years/cohorts). Overall, MAHA ELEVATE is essentially a CMS-funded, real-world test of structured lifestyle and whole-person intervention packages, with heavy emphasis on rigorous evaluation, scalable operations, and credible evidence that the approach can improve outcomes and reduce costs for Medicare beneficiaries.
MAHA ELEVATE (CMS Innovation Center) - Frequently Asked Questions (FAQs)
1) What is the MAHA ELEVATE opportunity?
Make America Healthy Again - Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE) is a Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) cooperative agreement. It funds a voluntary, three-year service delivery model that tests evidence-based "whole-person" functional or lifestyle medicine approaches for Medicare beneficiaries.
2) What is the main goal of the model?
The model aims to test whether structured lifestyle-focused and whole-person interventions can improve health outcomes for Medicare beneficiaries while also lowering overall costs. The approach emphasizes moving upstream, focusing on prevention and earlier intervention rather than only managing chronic diseases after they develop.
3) What does CMS mean by "whole-person FLM" in this notice?
CMS uses the phrase "whole-person FLM" as a descriptive label for a bundle of services often associated with functional or lifestyle medicine that are not currently covered under Medicare. The term is used for the purposes of this test model only.
4) Does this opportunity create a new Medicare benefit or change Medicare coverage?
No. CMS explicitly states that the "whole-person FLM" terminology is not intended to set a new industry standard, create new practice guidelines, or establish a new Medicare-covered benefit category. It should not be interpreted as changing Medicare coverage policy outside the boundaries of this demonstration.
5) How long is the MAHA ELEVATE model period?
The model is described as a voluntary, three-year service delivery model.
6) When does the model start?
The model will run in two cohorts that begin one year apart, starting in 2026 and 2027.
7) How many recipients does CMS plan to select?
CMS plans to select up to 30 recipients total across the two cohorts. The published opportunity details also anticipate 15 awards, suggesting awards may be distributed across years/cohorts.
8) What kinds of interventions is CMS looking to fund?
CMS is looking to evaluate structured, evidence-based whole-person functional or lifestyle medicine approaches that combine psychological, nutritional, and physical strategies and tailor those strategies to the individual. The model is intended to support prevention and earlier intervention and to test whether this approach improves outcomes and reduces costs.
9) What are the main application evaluation criteria?
Applications are judged using five main criteria:
- The design of the whole-person FLM intervention, including a credible path to cost savings
- The plan for beneficiary recruitment and the study design, including how participants will be assigned or randomized
- Organizational and administrative capacity to run a multi-year service delivery model
- Data management capabilities to support extensive reporting and evaluation needs
- The reasonableness and appropriateness of the proposed budget
10) How important is evidence and prior implementation experience?
CMS signals that competitive applications should include solid evidence supporting the intervention and proof that the applicant has already implemented similar approaches successfully. CMS also indicates that measurable results, including cost savings, strengthen an application.
11) What does CMS expect regarding beneficiary recruitment?
The model includes minimum beneficiary participation targets and requires a clear recruitment plan. Applicants are evaluated on their plan for beneficiary recruitment and their study design, including how participants will be assigned or randomized.
12) What are the expectations around evaluation rigor and study design?
CMS emphasizes the operational reality of executing a rigorous evaluation. Applications are assessed on study design and on how participants will be assigned or randomized, along with the applicant's ability to support extensive reporting and evaluation needs through strong data management capabilities.
13) Are partnerships required?
Partnerships may be necessary depending on the applicant. CMS cautions that organizations that do not directly provide clinical care will likely need formal partnerships with entities that do (for example, practices, clinics, health systems, or other care delivery organizations) to enroll beneficiaries, deliver the intervention, and collect high-quality evaluation data.
14) Who is eligible to apply?
Eligibility is broad and effectively unrestricted at the organizational level, but individuals cannot apply. Examples of eligible applicants include:
- Private medical practices
- Health systems and Accountable Care Organizations (ACOs)
- Academic organizations
- Functional, lifestyle, preventive, or integrative medicine centers
- Community-based organizations
- Federally Qualified Health Centers (FQHCs)
- Rural Health Clinics (RHCs)
- Indian Health Service/Tribal/Urban Indian programs (I/T/Us)
- Local or state governments
- Multi-state organizations
15) Can an individual apply for MAHA ELEVATE?
No. The opportunity is open to organizations, but individuals cannot apply.
16) What is the funding mechanism for this opportunity?
This is a discretionary funding opportunity using a cooperative agreement mechanism. A cooperative agreement typically means CMS expects substantial involvement in shaping or overseeing how the work is carried out compared with a standard grant.
17) What is the CFDA number for this opportunity?
The CFDA number listed for this discretionary funding opportunity is 93.779.
18) What is the funding opportunity number?
The funding opportunity number is CMS-2W2-27-001.
19) What is the application deadline?
The application deadline is May 15, 2026.
20) What is the maximum award amount?
The listed award ceiling is $3,300,000.
21) How does CMS describe the overall purpose of MAHA ELEVATE?
Overall, MAHA ELEVATE is a CMS-funded, real-world test of structured lifestyle and whole-person intervention packages, with heavy emphasis on rigorous evaluation, scalable operations, and credible evidence that the approach can improve outcomes and reduce costs for Medicare beneficiaries.
22) What operational capabilities does CMS appear to prioritize?
Beyond clinical logic, CMS emphasizes practical execution. Strong applicants are expected to demonstrate organizational and administrative capacity to run a multi-year service delivery model and data management capabilities to handle extensive reporting and evaluation requirements.
23) What does CMS look for in a proposed budget?
Budget review is one of the five stated evaluation criteria. CMS evaluates the reasonableness and appropriateness of the proposed budget in relation to the planned intervention, recruitment, service delivery operations, and required reporting and evaluation activities.
24) Is the model mandatory for beneficiaries?
No. The model is described as voluntary.
Browse more opportunities from the same category: Health
Next opportunity: Freedom 250 – Amplifying Exchange Alumni stories of excellence
Previous opportunity: Managing Restrictive Housing Populations Training
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CMS 2W2 27 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CMS 2W2 27 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 27 012 Funding Number: PAR 27 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 27 011 Funding Number: PAR 27 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 27 013 Funding Number: PAR 27 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Delta Health Care Service Grant Program Apply for RDBCP DHCS 2026 Funding Number: RDBCP DHCS 2026 Agency: Rural Business-Cooperative Service Category: Health Funding Amount: $1,000,000 |
| Title X Family Planning Services Grants Apply for PA FPH 27 001 Funding Number: PA FPH 27 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $22,000,000 |
| Cooperative Research Agreements Related to the World Trade Center Health Program (U01) Apply for RFA OH 26 001 Funding Number: RFA OH 26 001 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $550,000 |
| Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) Apply for PAR 27 015 Funding Number: PAR 27 015 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional) Apply for RFA HD 27 012 Funding Number: RFA HD 27 012 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 27 073 Funding Number: PAR 27 073 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) Apply for RFA DE 27 001 Funding Number: RFA DE 27 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) Apply for RFA CA 27 016 Funding Number: RFA CA 27 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) Apply for RFA DE 27 002 Funding Number: RFA DE 27 002 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Apply for PAR 27 077 Funding Number: PAR 27 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional) Apply for RFA DK 27 146 Funding Number: RFA DK 27 146 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required) Apply for RFA MH 27 135 Funding Number: RFA MH 27 135 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) Apply for RFA DC 27 004 Funding Number: RFA DC 27 004 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) Apply for RFA HL 27 004 Funding Number: RFA HL 27 004 Agency: National Institutes of Health Category: Health Funding Amount: $85,000 |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 27 083 Funding Number: PAR 27 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) Apply for PAR 27 075 Funding Number: PAR 27 075 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed) Apply for RFA MH 27 205 Funding Number: RFA MH 27 205 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CMS 2W2 27 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.